Beta-endorphin. Biological activity of synthetic analogs with analgesia inhibiting property in rat vas deferens and guinea pig ileum assays.
Three synthetic analogs of human beta-endorphin (beta h-EP) (I, [Gln8, Gly31]-beta h-EP-Gly-Gly-NH2; II, [Arg9,12,24,28,29]-beta h-EP and III, [Cys11,26, Phe27, Gly31]-beta h-EP), which have been shown to possess potent inhibiting activity to beta h-EP-induced analgesia, were assayed in rat vas deferens and guinea pig ileum bioassay systems. In the rat vas deferens assay, relative potencies of these analogs were beta h-EP, 100; I, 30; II, 40; III, 1, whereas in the guinea pig ileum assay: beta h-EP, 100; I, 184; II, 81; III, 163. From previous studies on their analgesia potency in mice and opiate receptor-binding activity in rat brain membranes, their activity in rat vas deferens correlates well with the analgesic potency and the activity from guinea pig ileum assay shows good correlations with that from the opiate receptor-binding assay.
Ho
C L
CL
Li
C H
CH
D000698:Analgesia; D000818:Animals; D004558:Electric Stimulation; D004723:Endorphins / Q000494:pharmacology*; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D051381:Rats; D014649:Vas Deferens / Q000187:drug effects*; D001615:beta-Endorphin / Q000031:analogs & derivatives
D004723:Endorphins; D001615:beta-Endorphin; C045429:beta-endorphin, Gln(8),Gly(31)-Gly-Gly-NH2-; C045431:beta-endorphin, Cys(11,26),Phe(27), Gly(31)-; C045430:beta-endorphin, Arg(9,12,24,28,29)-